AZ-2J-ANTENNAS
2J Antennas “Connecting the World”, a global leader in high performance antenna solutions, introduces the world’s smallest flexible antenna to their brand new Mono-Flexi Series . The cutting-edge patent pending technology solves the antenna performance vs. size challenge by introducing a new technique of cable bridging between radiation elements and the extension ground plane, making it ideal for small device integration. The bridging technique creates lower resonances and optimizes tuning while reducing the antenna size with maximum efficiency, especially across low frequency bands.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210817005773/en/
The Mono-Flexi Series is composed of miniature antennas that cover sub-6GHz, 5G NR, 4G LTE and Cellular 600 - 7125 MHz spectrums. GNSS Multi-Constellation, WiFi-6 and ISM band models are under development and will be added to the Mono-Flexi Series in the near future. Right and left hand feed options allow various antenna configurations for MIMO and array systems. This high efficiency antenna is ideal for PCB or cellular devices integration that faces difficulties during certifications, carrier approvals or size restrictions. With this technology, we are able to reduce the size of 4G LTE antennas to 40x20 mm and for 5G NR to 50x25 mm, with a low profile of 0.2mm. Mono-Flexi Series antennas are able to reach above 80% efficiency in the lower frequency bands, making a breakthrough technology now available to the market.
“We are proud to be the first to offer the smallest flexible antenna solutions to the global market. With a growing demand for smaller devices, antenna solutions must continuously innovate with more advanced technologies. Our engineering teams have worked tirelessly developing the smallest full spectrum antenna solution that closes the antenna size vs. performance gap,” states Ruben Cuadras, PhD., Director of Engineering.
About 2J Antennas
Since 2002, 2J Antennas has worked closely with technological innovators catering to medical, automotive, marine, telematics, telecommunication, automation and IoT industry leaders. With a reputation for engineering excellence and self-sufficiency, 2J Antennas is committed to high quality products and a full suite of services that help customers bring their products to market with little to no effort by providing a true end-to-end process.
A comprehensive range of off-the-shelve antennas and customized solutions can be found on their website or by contacting them at sales@2j-antennas.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210817005773/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Parse Biosciences and Codebreaker Labs Partner to Apply Whole Transcriptome Single Cell Profiling and Causal Genomics at Scale19.12.2025 14:00:00 CET | Press release
Collaboration pairs robust synthetic biology platform with massive scale single cell sequencing to overcome long-standing challenges in variant mapping Parse Biosciences, the leading provider of scalable and accessible single cell sequencing solutions, today announced a collaboration with Codebreaker Labs to develop and validate a breakthrough platform capable of testing thousands of genetic variants in parallel and measuring their effects at single cell resolution. By combining Codebreaker’s synthetic biology platform and variant engineering capabilities with the scale and accessibility of Parse’s Evercode™ technology, the collaboration aims to generate the causal data increasingly sought by AI developers, drug discovery teams, and clinical researchers. Today’s genomic studies rely heavily on observational data, or variants that appear in large populations. But rare and private variants, often only seen in one individual or family, are nearly impossible to study this way because too f
Cinemo Launches Cinemo ICO™, Accelerating the AI-Driven Intelligent Cockpit19.12.2025 11:00:00 CET | Press release
The future of in-car intelligence, delivered today for hyper-personalized, safer, smarter, and more exceptional journeys Cinemo, a global leader and highly innovative one-stop-shop provider for fully integrated digital media products announces today the launch of its next-generation, AI-powered cockpit solutions - Cinemo ICO™. By bringing agentic AI, Cinemo unlocks a truly intelligent cockpit - connecting vehicles, drivers, passengers, and their digital ecosystems into one seamless, personal and context-aware flow. The first product launched within the Cinemo ICO™ portfolio is Cinemo ICO™ MediaMind, enabling advanced intelligent media discovery. It combines the latest agentic AI technology with Cinemo’s core expertise of providing automotive-grade media management, helping users effortlessly discover the right content for every ride - perfectly matched to their taste, context, and environment. With Cinemo ICO™ MediaMind, the digital media experience evolves: using cutting-edge large la
Cyviz Awarded Two Classified NATO Defense Contracts19.12.2025 08:00:00 CET | Press release
Norwegian technology and platform company Cyviz AS has been awarded two classified defense contracts by major European NATO-partner nations to deliver a fully mobile, containerised Command & Control (C2) capability, strengthening Europe’s operational readiness in high-threat and expeditionary environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218625485/en/ Image from a previous military exercise where Cyviz demonstrated a mobile command center solution. The contracts cover the design, integration, and delivery of secure, deployable operations centres engineered to NATO security standards, enabling military and security forces to establish full theatre-class command capability wherever operations require. Due to the sensitive nature of the missions, contract value and customer identities remain undisclosed. From Demonstrated Readiness to Operational Deployment The awards follow growing interest among European def
S3NS Announces SecNumCloud Qualification for PREMI3NS, its Trusted Cloud Offering19.12.2025 07:00:00 CET | Press release
PREMI3NS, S3NS’ (pronounced “sense”) trusted cloud offering, has now received ANSSI’s SecNumCloud qualification, meeting the most stringent protection requirements against extraterritorial laws in France and Europe The fruition of the partnership between Thales and Google Cloud enables organizations from the private and public sectors to innovate and transform with one of the broadest ranges of managed services in a trusted cloud environment Early adopters of S3NS include companies from the insurance, manufacturing, healthcare and finance industries S3NS, a subsidiary of Thales in partnership with Google Cloud, today announced that PREMI3NS, its "Trusted Cloud" (Cloud de confiance) offering, has received the SecNumCloud 3.2 qualification delivered by the French National Agency for the Security of Information Systems (ANSSI). Meeting SecNumCloud 3.2’s protection and resilience requirements, which are known as the most demanding ones in France and Europe, it offers immunity from non-Euro
Meiji Seika Pharma Partners With MBC BioLabs to Strengthen Global Innovation in Drug Discovery19.12.2025 02:00:00 CET | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Chuo-ku, Tokyo; President & CEO: Toshiaki Nagasato) today announced that it has entered into a partnership agreement with MBC BioLabs which is a private organization supporting the development of biotech startup companies in California’s San Francisco Bay Area. MBC BioLabs provides fully equipped research facilities and a supportive community that help biotech entrepreneurs accelerate from concept to company. By removing the burden of building and maintaining laboratory infrastructure, resident companies can focus early on research and development while efficiently advancing commercialization. Through this partnership, Meiji Seika Pharma will further advance its open-innovation initiatives and strengthen research and development in its priority therapeutic areas: infectious diseases, hematologic diseases, and immune-inflammatory diseases. By engaging with the entrepreneurs and startup community at MBC BioLabs, the company aims to discover inn
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom